Enlivex Therapeutics is blending biotech with blockchain. The clinical-stage company is deploying funds from its $212 million PE deal to build a crypto treasury Post navigation Myriad Markets adopts World Liberty Fi’s USD1 as exclusive settlement assetBitnomial launches first-ever Aptos futures in the US
